Four cases of Trousseau syndrome associated with breast cancer that exhibited central nervous system manifestations.

Breast cancer Trousseau syndrome Venous thromboembolism

Journal

International cancer conference journal
ISSN: 2192-3183
Titre abrégé: Int Cancer Conf J
Pays: Singapore
ID NLM: 101734231

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 13 01 2020
accepted: 16 03 2020
entrez: 26 6 2020
pubmed: 26 6 2020
medline: 26 6 2020
Statut: epublish

Résumé

Cancer-associated thrombosis is known as Trousseau syndrome (TS). Here, we report 4 cases of TS associated with advanced breast cancer that caused central nervous system (CNS) vascular events. All 4 patients experienced sudden onset of CNS symptoms. Imaging revealed multiple brain infarctions or intracranial hemorrhage and all 4 patients had leptomeningeal or brain metastasis. Laboratory findings showed hypercoagulability at diagnosis of TS. Of the 4 patients, 2 patients were treated with unfractionated heparin, while 2 patients could not undergo anticoagulant therapy. In all patients, once the TS occurred, the CNS symptoms progressed rapidly and the prognosis was very poor, 3 patients dying within about a month of diagnosis of TS. Therefore, the predictive factors of TS are important and standards and guidelines for administration of anticoagulants are needed.

Identifiants

pubmed: 32582520
doi: 10.1007/s13691-020-00411-9
pii: 411
pmc: PMC7297874
doi:

Types de publication

Case Reports

Langues

eng

Pagination

146-150

Informations de copyright

© The Japan Society of Clinical Oncology 2020.

Déclaration de conflit d'intérêts

Conflict of interestThe authors declare that they have no conflict of interest.

Références

Curr Oncol. 2008 Jan;15(Suppl 1):S58-67
pubmed: 18231650
Ann N Y Acad Sci. 1974;230:262-70
pubmed: 4522873
J Thromb Haemost. 2007 Mar;5(3):632-4
pubmed: 17319909
J Thromb Haemost. 2013 Jan;11(1):56-70
pubmed: 23217107
J Clin Invest. 2003 Sep;112(6):853-62
pubmed: 12975470
Jpn J Clin Oncol. 2016 Mar;46(3):204-8
pubmed: 26546690
J Clin Oncol. 2004 May 15;22(10):1944-8
pubmed: 15143088
Mol Clin Oncol. 2016 Jul;5(1):138-142
pubmed: 27330786
Blood. 2007 Sep 15;110(6):1723-9
pubmed: 17496204
J Oncol Pract. 2015 May;11(3):e442-4
pubmed: 25873061
Intern Med. 2012;51(9):1099-102
pubmed: 22576395

Auteurs

Mai Okazaki (M)

Graduate School of Comprehensive Human Sciences Majors of Medical Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki Japan.
Department of Breast-Thyroid-Endocrine Surgery, University of Tsukuba Hospital, 2-1-1 Amakubo, Tsukuba, Ibaraki Japan.

Hiroko Bando (H)

Department of Breast-Thyroid-Endocrine Surgery, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki Japan.

Emika Ichioka (E)

Department of Breast-Thyroid-Endocrine Surgery, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki Japan.

Akiko Iguchi-Manaka (A)

Department of Breast-Thyroid-Endocrine Surgery, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki Japan.

Katsuhiro Nasu (K)

Department of Diagnostic Radiology, University of Tsukuba Hospital, 2-1-1 Amakubo, Tsukuba, Ibaraki Japan.

Hisato Hara (H)

Department of Breast-Thyroid-Endocrine Surgery, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki Japan.

Classifications MeSH